(NASDAQ: OMGA) Omega Therapeutics's forecast annual revenue growth rate of 306.75% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Omega Therapeutics's revenue in 2024 is $3,094,000.On average, 2 Wall Street analysts forecast OMGA's revenue for 2024 to be $204,073,445, with the lowest OMGA revenue forecast at $187,526,949, and the highest OMGA revenue forecast at $220,619,940. On average, 1 Wall Street analysts forecast OMGA's revenue for 2025 to be $220,619,940, with the lowest OMGA revenue forecast at $220,619,940, and the highest OMGA revenue forecast at $220,619,940.
In 2027, OMGA is forecast to generate $1,656,579,974 in revenue, with the lowest revenue forecast at $182,011,451 and the highest revenue forecast at $3,131,148,498.